Organon & Co to buy Riovant’s arm Dermavant Sciences for $1.2 billion
US-based pharmaceutical company Organon & Co., will acquire Riovant Sciences Ltd’s arm — Dermavant Sciences Ltd., specialising in immuno-dermatology — for $1.2 billion.
Drugs
Health
Pharma